Exosomes in Atherosclerosis, a Double-Edged Sword: Their Role in Disease Pathogenesis and Their Potential As Novel Therapeutics
Overview
Authors
Affiliations
Cardiovascular disease (CAD) due to atherosclerosis is a major cause of death worldwide. The development of atherosclerosis involves intercellular communication facilitated by exosomes secreted from vascular endothelial cells (VECs), vascular smooth muscle cells (VSMCs), immune cells, and platelets. In this review, we summarize the current understanding of exosome biogenesis and uptake, and discuss atherogenic and atheroprotective functions of exosomes secreted from these cell types. In addition, we examine the potential of enhancing the therapeutic and targeting ability of exosomes exhibiting atheroprotective function by drug loading and surface modification with targeting ligands. We conclude with current challenges associated with exosome engineering for therapeutic use.
Engineered exosomes as a prospective therapy for diabetic foot ulcers.
Guo L, Xiao D, Xing H, Yang G, Yang X Burns Trauma. 2024; 12:tkae023.
PMID: 39026930 PMC: 11255484. DOI: 10.1093/burnst/tkae023.
Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases.
Xu C, Jiang C, Li Z, Gao H, Xian J, Guo W MedComm (2020). 2024; 5(8):e660.
PMID: 39015555 PMC: 11247338. DOI: 10.1002/mco2.660.
Broader Perspective on Atherosclerosis-Selected Risk Factors, Biomarkers, and Therapeutic Approach.
Fularski P, Czarnik W, Dabek B, Lisinska W, Radzioch E, Witkowska A Int J Mol Sci. 2024; 25(10).
PMID: 38791250 PMC: 11121693. DOI: 10.3390/ijms25105212.
Qin J, Zhou L, Yu L, Ye J, Wang F, Zhou J Front Pharmacol. 2024; 15:1365928.
PMID: 38756375 PMC: 11096520. DOI: 10.3389/fphar.2024.1365928.
The Landscape of Exosomes Biogenesis to Clinical Applications.
Al-Madhagi H Int J Nanomedicine. 2024; 19:3657-3675.
PMID: 38681093 PMC: 11048319. DOI: 10.2147/IJN.S463296.